Gabriella Almberg | Head of Health System Policy & Public Affairs
UCB
Appearances:
Day 2 - Wednesday 29 October @ 09:45
Keynote panel: New treatments on the block – 2025’s rare disease pipeline
-What are the most exciting new drugs on RDs therapies and gene therapies on the horizon?
-How are policies adapting to meet the increase of new approvals?
-How do we keep rare disease drug development sustainable? Supporting a better economic, policy and regulatory framework to incentivise companies
last published: 10/Sep/25 17:05 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events